{
    "title": "110_s2470",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Dehydroepiandrosterone Abuse \nReduction Act of 2007''.\n\nSEC. 2. DEHYDROEPIANDROSTERONE.\n\n    (a) In General.--Part D of title II of the Controlled Substances \nAct (21 U.S.C. 841 et seq.) is amended by adding at the end the \nfollowing:\n\n``SEC. 424. CIVIL PENALTIES FOR CERTAIN DEHYDROEPIANDROSTERONE SALES.\n\n    ``(a) In General.--\n            ``(1) Sale.--\n                    ``(A) In general.--Except as provided in paragraph \n                (2), it shall be unlawful for any person to knowingly \n                sell, cause another to sell, or conspire to sell a \n                product containing dehydroepiandrosterone to an \n                individual under the age of 18 years, including any \n                such sale using the Internet.\n                    ``(B) Failure to check identification.--If a person \n                fails to request identification from an individual \n                under the age of 18 years and sells a product \n                containing dehydroepiandrosterone to that individual, \n                that person shall be deemed to have known that the \n                individual was under the age of 18 years.\n                    ``(C) Affirmative defense.--It shall be an \n                affirmative defense to an alleged violation of \n                subparagraph (A) that the person selling a product \n                containing dehydroepiandrosterone examined the \n                purchaser's identification card and, based on that \n                examination, that person reasonably concluded that the \n                identification was valid and indicated that the \n                purchaser was not less than 18 years of age.\n            ``(2) Exception.--This section shall not apply to any sale \n        made pursuant to a validly issued prescription.\n    ``(b) Fines.--\n            ``(1) In general.--The Attorney General may impose a civil \n        penalty on a person for violating subsection (a)(1)(A), \n        including a violation of that subsection committed by an \n        employee or agent of such person.\n            ``(2) Maximum amount.--A civil penalty imposed under \n        paragraph (1) shall be--\n                    ``(A) not more than $1,000 for the first violation \n                of subsection (a)(1)(A) by a person;\n                    ``(B) not more than $2,000 for the second violation \n                of subsection (a)(1)(A) by a person; and\n                    ``(C) not more than $5,000 for the third violation, \n                or a subsequent violation, of subsection (a)(1)(A) by a \n                person.\n            ``(3) Number of violations.--If a person makes sales of \n        dehydroepiandrosterone at more than 1 location, for purposes of \n        determining the number of violations by that person under this \n        subsection each individual location operated by that person \n        shall be considered a separate person.\n    ``(c) Definition of Identification Card.--In this section, the term \n`identification card' means an identification card that--\n            ``(1) includes a photograph and the date of birth of the \n        individual;\n            ``(2) is issued by a State or the Federal Government; and\n            ``(3) is considered acceptable for purposes of sections \n        274a.2(b)(1)(v)(A) and 274a.2(b)(1)(v)(B)(1) of title 8, Code \n        of Federal Regulations (as in effect on or after the date of \n        the enactment of the Dehydroepiandrosterone Abuse Reduction Act \n        of 2007).''.\n    (b) Regulations.--\n            (1) Internet sales.--Not later than 180 days after the date \n        of enactment of this Act, the Attorney General of the United \n        States shall promulgate regulations for Internet sales of \n        products containing dehydroepiandrosterone to ensure compliance \n        with section 424 of the Controlled Substances Act, as added by \n        this Act.\n            (2) Civil penalties.--\n                    (A) In general.--Not later than 180 days after the \n                date of enactment of this Act, the Attorney General of \n                the United States shall promulgate regulations to carry \n                out section 424 of the Controlled Substances Act, as \n                added by this Act.\n                    (B) Contents.--The regulations promulgated under \n                subparagraph (A) shall--\n                            (i) provide for a range of fines for a \n                        retailer, based on whether the retailer or an \n                        employee or agent of that retailer has \n                        committed prior violations of section 424(a) of \n                        the Controlled Substances Act, as added by this \n                        Act; and\n                            (ii) require consideration of whether a \n                        fine to be imposed on a retailer should be \n                        reduced or eliminated based on--\n                                    (I) the establishment and \n                                administration of an effective employee \n                                training program by a retailer relating \n                                to this Act and the amendments made by \n                                this Act; or\n                                    (II) other actions taken by a \n                                retailer to ensure compliance with this \n                                Act and the amendments made by this \n                                Act.\n            (3) Definition of retailer.--In this subsection, the term \n        ``retailer'' means a grocery store, general merchandise store, \n        drug store, convenience store, or other entity or person whose \n        activities as a distributor relating to products containing \n        dehydroepiandrosterone are limited almost exclusively to sales \n        for personal use, both in number of sales and volume of sales, \n        either directly to walk-in customers or in face-to-face \n        transactions by direct sales.\n    (c) Technical and Conforming Amendment.--The table of contents for \nthe Comprehensive Drug Abuse Prevention and Control Act of 1970 (Public \nLaw 91-513; 84 Stat. 1236) is amended by inserting after the item \nrelating to section 423 the following:\n\n``Sec. 424. Dehydroepiandrosterone sales.''.\n    (d) Effect on State Law.--This section and the amendments made by \nthis section shall supersede any provision of the law of any State \nrelating to the sale of dehydroepiandrosterone."
}